你在乎的一切,都在一個地方

追蹤 feed:部落格、新聞、RSS 等等。用輕鬆的方式閱讀並吸收你選擇的內容。

取得 Feeder

腫瘤學 RSS feed

Feeder 使用者最常追蹤的 腫瘤學 RSS 摘要,包括 Nature Medicine、Massachusetts Medical Society: New England Journal of Medicine: Table of Contents 和 ClinicalTrials.gov: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days。複製 RSS 網址,或在 Feeder 免費追蹤。

相關主題

健康 RSS feed 臨床試驗 RSS feed 醫學研究 RSS feed 心理健康 RSS feed 心理學 RSS feed 公共衛生 RSS feed 製藥 RSS feed

建議編輯

Nature Medicine

nature.com

Original research articles published in Nature Medicine range from basic findings that have clear implications for disease pathogenesis and therapy to the earliest phases of human investigation. Aiming to keep Ph.D. and M.D. readers informed of a wide range of biomedical research findings, the journal publishes the latest advances in cancer biology, vascular biology, neuroscience, inflammatory disease, infectious disease and metabolic disorders, among other fields. Reviews, Perspectives and other commissioned content clarify and give context to these biomedical research advances, and the News section reports on the latest developments in drug research and development.

立即追蹤 100 位追蹤者

Massachusetts Medical Society: New England Journal of Medicine: Table of Contents

nejm.org

Table of Contents for New England Journal of Medicine. List of articles from both the latest and ahead of print issues.

立即追蹤 196 位追蹤者

ClinicalTrials.gov: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days

立即追蹤 71 位追蹤者

Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]

pubmed.ncbi.nlm.nih.gov

Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]: Latest results from PubMed

立即追蹤 162 位追蹤者

ClinicalTrials.gov: Ovarian Cancer | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Ovarian Cancer | Last update posted in the last 14 days

立即追蹤 152 位追蹤者

Nature Reviews Cancer

nature.com

Nature Reviews Cancer publishes a dynamic and accessible mix of Reviews, Perspectives, Progress and Highlight articles on the most important primary research papers. All Reviews and Perspectives are carefully commissioned, written by leaders in the field and subject to rigorous peer-review – so that readers receive independent, high-quality and authoritative articles in each issue. The journal’s broad scope captures the essence of modern multidisciplinary cancer research – integrating cancer biology with new approaches to treatment, diagnosis and prevention. Non-specialists will benefit from the glossary and highlighted references, busy scientists will appreciate the ‘At-a-glance’ summaries, and experts will value the insight provided by top names in their field. Nature Reviews Cancer is the premier teaching and reference resource in cancer and has become the ‘must read’ review journal of cancer researchers worldwide.

立即追蹤 52 位追蹤者

Nature Reviews Cancer - Issue - nature.com science feeds

nature.com

Nature Reviews Cancer publishes a dynamic and accessible mix of Reviews, Perspectives, Progress and Highlight articles on the most important primary research papers. All Reviews and Perspectives are carefully commissioned, written by leaders in the field and subject to rigorous peer-review – so that readers receive independent, high-quality and authoritative articles in each issue. The journal’s broad scope captures the essence of modern multidisciplinary cancer research – integrating cancer biology with new approaches to treatment, diagnosis and prevention. Non-specialists will benefit from the glossary and highlighted references, busy scientists will appreciate the ‘At-a-glance’ summaries, and experts will value the insight provided by top names in their field. Nature Reviews Cancer is the premier teaching and reference resource in cancer and has become the ‘must read’ review journal of cancer researchers worldwide.

立即追蹤 90 位追蹤者

ESMO News

esmo.org

The latest news from ESMO

立即追蹤 79 位追蹤者

ASCO: Journal of Clinical Oncology: Table of Contents

Table of Contents for Journal of Clinical Oncology. List of articles from both the latest and ahead of print issues.

立即追蹤 53 位追蹤者

Medical Xpress - latest medical and health news stories

medicalxpress.com

Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.

立即追蹤 140 位追蹤者

Endpoints News

endpoints.news

Biotech and pharma business news, with a focus on the science, people and money that drive the industry.

立即追蹤 28 位追蹤者

Cancer Cell

cell.com

Cancer Cell RSS feed.

立即追蹤 73 位追蹤者

Business Wire - News by Company: Verastem, Inc.

businesswire.com

Business Wire - The global leader in news distribution

立即追蹤 23 位追蹤者

The New England Journal of Medicine: Search Results in Hematology/Oncology

nejm.org

The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Hematology/Oncology. NEJM (https://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.

立即追蹤 24 位追蹤者

CAR T-cell Therapy

pubmed.ncbi.nlm.nih.gov

CAR T-cell Therapy: Latest results from PubMed

立即追蹤 16 位追蹤者

follicular lymphoma

pubmed.ncbi.nlm.nih.gov

follicular lymphoma: Latest results from PubMed

立即追蹤 14 位追蹤者

DLBCL

pubmed.ncbi.nlm.nih.gov

DLBCL: Latest results from PubMed

立即追蹤 12 位追蹤者

mantle cell lymphoma

pubmed.ncbi.nlm.nih.gov

mantle cell lymphoma: Latest results from PubMed

立即追蹤 12 位追蹤者

hodgkin lymphoma

pubmed.ncbi.nlm.nih.gov

hodgkin lymphoma: Latest results from PubMed

立即追蹤 12 位追蹤者

multiple myeloma

pubmed.ncbi.nlm.nih.gov

multiple myeloma: Latest results from PubMed

立即追蹤 12 位追蹤者

Cancer Cell

cell.com

Cancer Cell RSS feed.

立即追蹤 11 位追蹤者

Avenzo Therapeutics

avenzotx.com

Developing the next generation of oncology therapies for patients.

立即追蹤 < 10 位追蹤者